37.3 Million Americans have Diabetes: When will Congress Act?


Pharmacy Benefit Manager Transparency Act of 2022
Staffers from Senator Chuck Grassley’s office joined us to discuss their legislative solutions to the convoluted PBM system, including the Pharmacy Benefit Manager Transparency Act of 2022. The bill was recently introduced by Senator Grassley and Senator and Commerce Committee Chair Maria Cantwell of Washington. The PBM Transparency Act calls on the Federal Trade Commission to address PBM practices impacting patients and payers and inject much-needed transparency into the drug pricing system. 

Cures 2.0
Passed in 2016, the 21st Century Cures Act has been a game-changer for many patients. By accelerating medical product development and approvals, new innovations are reaching patients faster than ever before. Congresswoman DeGette and her colleague, Congressman Fred Upton, discussed their proposed follow-on Cures 2.0.

DeGette and Upton underscored the importance of Cures 2.0 provisions to accelerate patient access to innovative treatments by fully funding federal research and providing regulators with the resources needed to review safety and efficacy. Innovation has transformed the landscape for diabetes management, which DeGette has experienced in her own family, after her daughter was diagnosed with type 1 diabetes. She shared how rapid and equitable coverage of innovative treatments in federal programs is critical for Americans with diabetes and to reduce costs for the U.S. healthcare system.

Treat and Reduce Obesity Act of 2021
Diabetes prevention is just as important as the research and addressing affordability issues. Obesity can play a critical role in the development of type 2 diabetes; obesity occurs in 90 percent of US adults aged 18 years or older who are diagnosed with diabetes. As a doctor Congressman Brad Wenstrup understands the health implications of obesity and the stigma that prevents patients from getting the treatments they need. He has worked to get the Treat and Reduce Obesity Act of 2021 passed so FDA-approved medications for chronic weight management and obesity treatment from nutritionists, clinical psychologists and dietitians are covered by Medicare.

Congressman Donald Payne of New Jersey shared some of his personal experience living with type 2 diabetes and its complications. He is co-sponsoring TROA and other legislation to help people with or at risk for the disease and address diabetes disparities in communities of color and other disproportionately impacted populations.



Read More: 37.3 Million Americans have Diabetes: When will Congress Act?

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More